Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
26
IBAT.V Quote, Financials, Valuation and Earnings
Last price:
$0.1400
Seasonality move
:
-5.33%
Day range:
$0.1300 - $0.1500
52-week range:
$0.1300 - $0.9100
Dividend yield:
0%
P/E ratio:
3.15x
P/S ratio:
41.17x
P/B ratio:
1.00x
Volume:
44.8K
Avg. volume:
60.7K
1-year change:
-74.14%
Market cap:
$44.5M
Revenue:
$1.2M
EPS (TTM):
$0.05
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $1.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $1.4M | $1.5M | $9.8M | |
| Gross Profit | -- | -- | -$1.4M | -$1.5M | -$8.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -707.36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $9.9M | $12.8M | $12.6M | |
| Other Inc / (Exp) | -- | -- | $6.4M | $2.8M | -- | |
| Operating Expenses | -- | -- | $9.9M | $12.8M | $13.3M | |
| Operating Income | -- | -- | -$11.3M | -$14.3M | -$21.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$5M | -$11.5M | -$4.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$5M | -$11.5M | -$4.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$5M | -$11.5M | -$4.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.03 | -$0.06 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.03 | -$0.06 | -$0.02 | |
| Weighted Average Basic Share | -- | -- | $142.1M | $204.2M | $238.4M | |
| Weighted Average Diluted Share | -- | -- | $142.1M | $204.2M | $238.4M | |
| EBITDA | -- | -- | -$9.9M | -$12.8M | -$18.2M | |
| EBIT | -- | -- | -$11.3M | -$14.3M | -$21.8M | |
| Revenue (Reported) | -- | -- | -- | -- | $1.2M | |
| Operating Income (Reported) | -- | -- | -$11.3M | -$14.3M | -$21.8M | |
| Operating Income (Adjusted) | -- | -- | -$11.3M | -$14.3M | -$21.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $871.6K | $88.1K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -73.81% | |
| Cost of Revenues | -- | -- | $360.8K | $3.6M | $1.8M | |
| Gross Profit | -- | -- | -$360.8K | -$2.7M | -$1.7M | |
| Gross Profit Margin | -- | -- | -- | -307.5% | -1921.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $2.7M | $4M | $3M | |
| Other Inc / (Exp) | -- | -- | $116.6K | $28.4M | -- | |
| Operating Expenses | -- | -- | $2.7M | $4M | $3M | |
| Operating Income | -- | -- | -$3M | -$6.7M | -$4.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$607.6K | $21.7M | $4.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$1.3M | $21.7M | $4.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$607.6K | $21.7M | $4.1M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.00 | $0.09 | $0.01 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.00 | $0.09 | $0.01 | |
| Weighted Average Basic Share | -- | -- | $202.6M | $242.7M | $287M | |
| Weighted Average Diluted Share | -- | -- | $202.6M | $246.3M | $291.6M | |
| EBITDA | -- | -- | -$2.7M | -$4.6M | -$3.7M | |
| EBIT | -- | -- | -$3M | -$6.7M | -$4.7M | |
| Revenue (Reported) | -- | -- | -- | $871.6K | $88.1K | |
| Operating Income (Reported) | -- | -- | -$3M | -$6.7M | -$4.7M | |
| Operating Income (Adjusted) | -- | -- | -$3M | -$6.7M | -$4.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.2M | $963.8K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $1.5M | $7.3M | $8.9M | |
| Gross Profit | -- | -- | -$1.1M | -$6.1M | -$8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $13.6M | $12.5M | $13.1M | |
| Other Inc / (Exp) | -- | -- | -$799K | $23M | -- | |
| Operating Expenses | -- | -- | $12.7M | $12.6M | $13.1M | |
| Operating Income | -- | -- | -$13.8M | -$18.7M | -$21.1M | |
| Net Interest Expenses | -- | -- | $15.6K | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$12.5M | $6.9M | $11.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$13.3M | -- | $13.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$12.5M | $6.9M | $12.8M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.08 | $0.02 | $0.05 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.08 | $0.02 | $0.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$12.3M | -$15.3M | -$15.9M | |
| EBIT | -- | -- | -$13.8M | -$18.7M | -$21.1M | |
| Revenue (Reported) | -- | -- | -- | $1.2M | $963.8K | |
| Operating Income (Reported) | -- | -- | -$13.8M | -$18.7M | -$21.1M | |
| Operating Income (Adjusted) | -- | -- | -$13.8M | -$18.7M | -$21.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.2M | $97.8K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $331.5K | $683.1K | $729.3K | $6.6M | $3.7M | |
| Gross Profit | -$331.5K | -$683.1K | -$729.3K | -$5.4M | -$3.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1M | $7.2M | $6.8M | $6.4M | $6.2M | |
| Other Inc / (Exp) | -$124K | -$139K | $13.4K | $20.3M | -- | |
| Operating Expenses | $960.4K | $7.4M | $6.9M | $6.4M | $6.2M | |
| Operating Income | -$1.3M | -$8.1M | -$7.7M | -$11.8M | -$9.8M | |
| Net Interest Expenses | $3.7K | $39.9K | $5.4K | -- | -- | |
| EBT. Incl. Unusual Items | -$1.4M | -$7.8M | -$5.1M | $8.4M | $6.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$1.4M | -$7.8M | -$5.8M | $8.5M | $6.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4M | -$7.8M | -$5.1M | $8.4M | $6.4M | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.06 | -$0.03 | $0.03 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.06 | -$0.03 | $0.03 | $0.02 | |
| Weighted Average Basic Share | $247.6M | $271.4M | $403.3M | $467.9M | $564.4M | |
| Weighted Average Diluted Share | $247.6M | $271.4M | $403.3M | $471.4M | $569.1M | |
| EBITDA | -$960.4K | -$7.4M | -$6.9M | -$9.2M | -$7.6M | |
| EBIT | -$1.3M | -$8.1M | -$7.7M | -$11.8M | -$9.8M | |
| Revenue (Reported) | -- | -- | -- | $1.2M | $97.8K | |
| Operating Income (Reported) | -$1.3M | -$8.1M | -$7.7M | -$11.8M | -$9.8M | |
| Operating Income (Adjusted) | -$1.3M | -$8.1M | -$7.7M | -$11.8M | -$9.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $407.4K | $1.4M | $15.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $142.1K | $660.6K | |
| Inventory | -- | -- | -- | -- | $1.5M | |
| Prepaid Expenses | -- | -- | $372.7K | $391.1K | $154K | |
| Other Current Assets | -- | -- | $16.2K | $42K | -- | |
| Total Current Assets | -- | -- | $840.4K | $2M | $18M | |
| Property Plant And Equipment | -- | -- | $35.2M | $39.1M | $41.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $7.3M | $5.9M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $43.7M | $46.9M | $64M | |
| Accounts Payable | -- | -- | -- | -- | $1.9M | |
| Accrued Expenses | -- | -- | $400.3K | $802.9K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $128.5K | $90.7K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $2.9M | $3.6M | $3.7M | |
| Long-Term Debt | -- | -- | $90.7K | -- | $205.8K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $3.7M | $9.5M | $25.7M | |
| Common Stock | -- | -- | $77.2M | $86.2M | $95.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | $40M | $37.5M | $38.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $40M | $37.5M | $38.3M | |
| Total Liabilities and Equity | -- | -- | $43.7M | $46.9M | $64M | |
| Cash and Short Terms | -- | -- | $407.4K | $1.4M | $15.5M | |
| Total Debt | -- | -- | $90.7K | -- | $205.8K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $1.6M | $11.3M | $13.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $1.3M | $709.6K | |
| Inventory | -- | -- | -- | $1.4M | $1.5M | |
| Prepaid Expenses | -- | -- | $1.1M | -- | $292.2K | |
| Other Current Assets | -- | -- | -- | $333.7K | -- | |
| Total Current Assets | -- | -- | $2.7M | $14.4M | $15.9M | |
| Property Plant And Equipment | -- | -- | $35.3M | $38.2M | $39M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $6.1M | $5.1M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $44.1M | $57.7M | $58.6M | |
| Accounts Payable | -- | -- | -- | $1.8M | $1.5M | |
| Accrued Expenses | -- | -- | $307.8K | $586.3K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $133K | $23K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $3.1M | $2.4M | $2.5M | |
| Long-Term Debt | -- | -- | $22.9K | -- | $132.2K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $3.1M | $9M | $13.9M | |
| Common Stock | -- | -- | $69.2M | $89M | $93.3M | |
| Other Common Equity Adj | -- | -- | $19.8M | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $41M | $48.7M | $44.7M | |
| Total Liabilities and Equity | -- | -- | $44.1M | $57.7M | $58.6M | |
| Cash and Short Terms | -- | -- | $1.6M | $11.3M | $13.1M | |
| Total Debt | -- | -- | $155.9K | -- | $132.2K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$5M | -$11.5M | -$4.9M | |
| Depreciation & Amoritzation | -- | -- | $1.4M | $1.5M | $3.7M | |
| Stock-Based Compensation | -- | -- | $3M | $3.9M | $2.5M | |
| Change in Accounts Receivable | -- | -- | -$35.7K | -$102.5K | -$468.7K | |
| Change in Inventories | -- | -- | -- | -- | -$1.5M | |
| Cash From Operations | -- | -- | -$8.2M | -$8M | -$18.7M | |
| Capital Expenditures | -- | -- | $4.3M | $3.5M | $1.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$4.3M | -$3.5M | -$1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $6.6K | -$404.6K | -- | |
| Cash From Financing | -- | -- | $3.3M | $12.5M | $34.1M | |
| Beginning Cash (CF) | -- | -- | $407.4K | $1.4M | $15.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$9.2M | $977.8K | $13.5M | |
| Ending Cash (CF) | -- | -- | -$9M | $2.4M | $29M | |
| Levered Free Cash Flow | -- | -- | -$12.5M | -$11.5M | -$20.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$1.3M | $21.7M | $4.1M | |
| Depreciation & Amoritzation | -- | -- | $353.5K | $2.1M | $1.1M | |
| Stock-Based Compensation | -- | -- | $489.2K | $1.1M | $571.1K | |
| Change in Accounts Receivable | -- | -- | $9.1K | -$872.4K | -$97.8K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$1.7M | -$5.4M | -$3.3M | |
| Capital Expenditures | -- | -- | $719.4K | $3.4K | $9.9K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$719.4K | -$3.4K | -$9.9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$30.5K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $11.1K | $830 | -- | |
| Cash From Financing | -- | -- | $135.1K | -$36.1K | $6.7M | |
| Beginning Cash (CF) | -- | -- | $1.6M | $11.3M | $13.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$104.7K | -- | -- | |
| Additions / Reductions | -- | -- | -$2.3M | -$5.4M | $3.3M | |
| Ending Cash (CF) | -- | -- | -$837.7K | $5.9M | $16.4M | |
| Levered Free Cash Flow | -- | -- | -$2.4M | -$5.4M | -$3.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$13.3M | -- | $13.2M | |
| Depreciation & Amoritzation | -- | -- | $1.5M | -- | $5.2M | |
| Stock-Based Compensation | -- | -- | $5M | -- | $1.9M | |
| Change in Accounts Receivable | -- | -- | $51.6K | -- | -$1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$7.1M | -- | -$17.1M | |
| Capital Expenditures | -- | -- | $3.7M | $2.8M | $811.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$3.7M | -- | -$811.1K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$100K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$402.5K | -$281.8K | -- | |
| Cash From Financing | -- | -- | $9.9M | -- | $6.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$1.1M | -- | -$11.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$10.8M | -- | -$17.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.4M | -$7.8M | -$5.8M | $8.5M | $6.4M | |
| Depreciation & Amoritzation | $331.5K | $683.1K | $722K | $2.6M | $2.1M | |
| Stock-Based Compensation | -- | $4.5M | $2.8M | $1.2M | $189.1K | |
| Change in Accounts Receivable | -$300 | -$5.9K | $47K | -$1.2M | -$182.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$631.3K | -$7M | -$4.3M | -$11.4M | -$8M | |
| Capital Expenditures | $274.9K | $1.5M | $1.3M | $1.3M | $495.7K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$871.1K | -$1.5M | -$1.3M | -$1.3M | -$495.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$9.4K | -$62.2K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$780.5K | -$403.8K | -$281.1K | -- | |
| Cash From Financing | $1.4M | $12.3M | $6.7M | $22.8M | $6.6M | |
| Beginning Cash (CF) | $299.6K | $11.9M | $5.5M | $28.1M | $22.7M | |
| Foreign Exchange Rate Adjustment | -$2.5K | -$7.4K | -$22.5K | -- | -- | |
| Additions / Reductions | -$132.4K | $3.8M | $1.2M | $10M | -$1.8M | |
| Ending Cash (CF) | $164.9K | $15.7M | $6.7M | $38.1M | $20.9M | |
| Levered Free Cash Flow | -$906.2K | -$8.4M | -$5.5M | -$12.8M | -$8.4M | |
Get IBAT.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBAT.V
Sector
P/E ratio
3.15x
19.88x
PEG ratio
--
-0.02x
P/B ratio
1.00x
1.85x
Price / LTM sales
41.17x
1.65x
Growth Metrics
IBAT.V
Sector
Revenue growth
-73.81%
2.4%
Earnings growth
124.02%
--
Revenue (5-year growth)
--
3.24%
Earnings forecast
--
$0.03
Profitability
IBAT.V
Sector
Profitability FY 2024
-$8.6M
--
Return on invested capital
32.58%
-9.18%
Return on assets
21.9%
-10.59%
Return on equity
32.74%
-9.79%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
11
Balance Sheet
IBAT.V
Sector
Total cash
$13.1M
$2.6M
Short term investments
--
$217K
Total assets
$64M
$16.7M
Long term debt
$132.2K
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 9
Bill Holdings, Inc. [BILL] is up 3.7% over the past day.
Buy
75
PRLB alert for Feb 9
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 9
Strategy, Inc. [MSTR] is up 2.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
